Remarkably, HLA class II‐restricted neoantigens have been identified as T‐cell targets in patients with HLA class II‐negative solid tumors 17, strongly suggesting that also neoantigens can be transferred from tumor cells to HLA class II‐positive APC for induction of specific CD4 T cells. This evidence concerns the gene CD4 and neoplasm.